Human Immunodeficiency Virus and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Human Immunodeficiency Virus (HIV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Immunodeficiency Virus (HIV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Immunodeficiency Virus (HIV) Overall Market Size
2.1 Global Human Immunodeficiency Virus (HIV) Market Size: 2022 VS 2030
2.2 Global Human Immunodeficiency Virus (HIV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Immunodeficiency Virus (HIV) Players in Global Market
3.2 Top Global Human Immunodeficiency Virus (HIV) Companies Ranked by Revenue
3.3 Global Human Immunodeficiency Virus (HIV) Revenue by Companies
3.4 Top 3 and Top 5 Human Immunodeficiency Virus (HIV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Immunodeficiency Virus (HIV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Players in Global Market
3.6.1 List of Global Tier 1 Human Immunodeficiency Virus (HIV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Immunodeficiency Virus (HIV) Market Size Markets, 2022 & 2030
4.1.2 Diagnosis
4.1.3 Treatment
4.2 By Type - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
4.2.1 By Type - Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2023
4.2.2 By Type - Global Human Immunodeficiency Virus (HIV) Revenue, 2024-2030
4.2.3 By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Immunodeficiency Virus (HIV) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.1.5 Homecare Settings
5.1.6 Others
5.2 By Application - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
5.2.1 By Application - Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2023
5.2.2 By Application - Global Human Immunodeficiency Virus (HIV) Revenue, 2024-2030
5.2.3 By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Human Immunodeficiency Virus (HIV) Market Size, 2022 & 2030
6.2 By Region - Global Human Immunodeficiency Virus (HIV) Revenue & Forecasts
6.2.1 By Region - Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2023
6.2.2 By Region - Global Human Immunodeficiency Virus (HIV) Revenue, 2024-2030
6.2.3 By Region - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.3.2 US Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.3.3 Canada Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.3.4 Mexico Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.4.2 Germany Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.3 France Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.4 U.K. Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.5 Italy Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.6 Russia Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.7 Nordic Countries Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.4.8 Benelux Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.5.2 China Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.3 Japan Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.4 South Korea Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.5 Southeast Asia Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.5.6 India Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.6.2 Brazil Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.6.3 Argentina Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, 2018-2030
6.7.2 Turkey Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7.3 Israel Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7.4 Saudi Arabia Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
6.7.5 UAE Human Immunodeficiency Virus (HIV) Market Size, 2018-2030
7 Human Immunodeficiency Virus (HIV) Companies Profiles
7.1 Gilead
7.1.1 Gilead Company Summary
7.1.2 Gilead Business Overview
7.1.3 Gilead Human Immunodeficiency Virus (HIV) Major Product Offerings
7.1.4 Gilead Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.1.5 Gilead Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Major Product Offerings
7.2.4 GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Human Immunodeficiency Virus (HIV) Major Product Offerings
7.3.4 Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Human Immunodeficiency Virus (HIV) Major Product Offerings
7.4.4 Merck Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Company Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Human Immunodeficiency Virus (HIV) Major Product Offerings
7.5.4 AbbVie Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.5.5 AbbVie Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Major Product Offerings
7.6.4 Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Major Product Offerings
7.7.4 Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Genentech
7.8.1 Genentech Company Summary
7.8.2 Genentech Business Overview
7.8.3 Genentech Human Immunodeficiency Virus (HIV) Major Product Offerings
7.8.4 Genentech Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.8.5 Genentech Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Human Immunodeficiency Virus (HIV) Major Product Offerings
7.9.4 Cipla Human Immunodeficiency Virus (HIV) Revenue in Global Market (2018-2023)
7.9.5 Cipla Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Human Immunodeficiency Virus (HIV) Market Opportunities & Trends in Global Market
Table 2. Human Immunodeficiency Virus (HIV) Market Drivers in Global Market
Table 3. Human Immunodeficiency Virus (HIV) Market Restraints in Global Market
Table 4. Key Players of Human Immunodeficiency Virus (HIV) in Global Market
Table 5. Top Human Immunodeficiency Virus (HIV) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Immunodeficiency Virus (HIV) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Immunodeficiency Virus (HIV) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Immunodeficiency Virus (HIV) Product Type
Table 9. List of Global Tier 1 Human Immunodeficiency Virus (HIV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Immunodeficiency Virus (HIV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Immunodeficiency Virus (HIV) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Immunodeficiency Virus (HIV) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2024-2030
Table 30. Gilead Company Summary
Table 31. Gilead Human Immunodeficiency Virus (HIV) Product Offerings
Table 32. Gilead Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Product Offerings
Table 36. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Human Immunodeficiency Virus (HIV) Product Offerings
Table 40. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Human Immunodeficiency Virus (HIV) Product Offerings
Table 44. Merck Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. AbbVie Company Summary
Table 47. AbbVie Human Immunodeficiency Virus (HIV) Product Offerings
Table 48. AbbVie Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Product Offerings
Table 52. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Product Offerings
Table 56. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Genentech Company Summary
Table 59. Genentech Human Immunodeficiency Virus (HIV) Product Offerings
Table 60. Genentech Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 61. Genentech Key News & Latest Developments
Table 62. Cipla Company Summary
Table 63. Cipla Human Immunodeficiency Virus (HIV) Product Offerings
Table 64. Cipla Human Immunodeficiency Virus (HIV) Revenue (US$, Mn) & (2018-2023)
Table 65. Cipla Key News & Latest Developments
List of Figures
Figure 1. Human Immunodeficiency Virus (HIV) Segment by Type in 2022
Figure 2. Human Immunodeficiency Virus (HIV) Segment by Application in 2022
Figure 3. Global Human Immunodeficiency Virus (HIV) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Immunodeficiency Virus (HIV) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Human Immunodeficiency Virus (HIV) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Revenue in 2022
Figure 8. By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 16. US Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 20. Germany Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 21. France Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 28. China Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 32. India Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 34. Brazil Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Human Immunodeficiency Virus (HIV) Revenue Market Share, 2018-2030
Figure 37. Turkey Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Human Immunodeficiency Virus (HIV) Revenue, (US$, Mn), 2018-2030
Figure 41. Gilead Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AbbVie Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Boehringer Ingelheim Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genentech Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cipla Human Immunodeficiency Virus (HIV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
